Vigna, G. B., Costantini, F., Aldini, G., Carini, M., Catapano, A., Schena, F., Tangerini, A., Zanca, R., Bombardelli, E., Morazzoni, P., Mezzetti, A., Fellin, R., and Maffei, Facino R. Effect of a standardized grape seed extract on low-density lipoprotein susceptibility to oxidation in heavy smokers. Metabolism 2003;52(10):1250-1257. View abstract.
Vitseva, O., Varghese, S., Chakrabarti, S., Folts, J. D., and Freedman, J. E. Grape seed and skin extracts inhibit platelet function and release of reactive oxygen intermediates. J Cardiovasc.Pharmacol. 2005;46(4):445-451. View abstract.
Wang, Y. J., Thomas, P., Zhong, J. H., Bi, F. F., Kosaraju, S., Pollard, A., Fenech, M., and Zhou, X. F. Consumption of grape seed extract prevents amyloid-beta deposition and attenuates inflammation in brain of an Alzheimer's disease mouse. Neurotox.Res 2009;15(1):3-14. View abstract.
Ward, N. C., Croft, K. D., Puddey, I. B., and Hodgson, J. M. Supplementation with grape seed polyphenols results in increased urinary excretion of 3-hydroxyphenylpropionic Acid, an important metabolite of proanthocyanidins in humans. J Agric.Food Chem 8-25-2004;52(17):5545-5549. View abstract.
Wen, W., Lu, J., Zhang, K., and Chen, S. Grape seed extract inhibits angiogenesis via suppression of the vascular endothelial growth factor receptor signaling pathway. Cancer Prev.Res (Phila) 2008;1(7):554-561. View abstract.
Winter, C. K. and Kurtz, P. H. Factors influencing grape worker susceptibility to skin rashes. Bull.Environ.Contam Toxicol. 1985;35(3):418-426. View abstract.
Xie, Q., Bedran-Russo, A. K., and Wu, C. D. In vitro remineralization effects of grape seed extract on artificial root caries. J Dent. 2008;36(11):900-906. View abstract.
Yamakoshi, J., Kataoka, S., Koga, T., and Ariga, T. Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 1999;142(1):139-149. View abstract.
Yamakoshi, J., Sano, A., Tokutake, S., Saito, M., Kikuchi, M., Kubota, Y., Kawachi, Y., and Otsuka, F. Oral intake of proanthocyanidin-rich extract from grape seeds improves chloasma. Phytother Res 2004;18(11):895-899. View abstract.
Yamasaki, R., Dekio, S., and Jidoi, J. Contact dermatitis from grape bud. Contact Dermatitis 1985;12(4):226-227. View abstract.
Zern, T. L., Wood, R. J., Greene, C., West, K. L., Liu, Y., Aggarwal, D., Shachter, N. S., and Fernandez, M. L. Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing oxidative stress. J Nutr. 2005;135(8):1911-1917. View abstract.
Calabrese, J. D. Spiritual healing and human development in the Native American church: toward a cultural psychiatry of peyote. Psychoanal.Rev. 1997;84(2):237-255. View abstract.
Carstairs SD, Cantrell FL. Peyote and mescaline exposures: a 12-year review of a statewide poison center database. Clin Toxicol (Phila). 2010;48(4):350-3. View abstract.
Franco-Molina, M., Gomez-Flores, R., Tamez-Guerra, P., Tamez-Guerra, R., Castillo-Leon, L., and Rodriguez-Padilla, C. In vitro immunopotentiating properties and tumour cell toxicity induced by Lophophora williamsii (peyote) cactus methanolic extract. Phytother.Res. 2003;17(9):1076-1081. View abstract.
Gilmore HT. Petoye use during pregnancy. S D J Med 2001;54:27-9. View abstract.
Henry, J. L., Epley, J., and Rohrig, T. P. The analysis and distribution of mescaline in postmortem tissues. J Anal.Toxicol 2003;27(6):381-382. View abstract.
Huttlinger, K. W. and Tanner, D. The Peyote way: implications for Culture Care theory. J.Transcult.Nurs. 1994;5(2):5-11. View abstract.
Lu, B. Y., Woofter, C., and Escalona, R. A case of prolonged peyote-induced psychosis resolved by sleep. J.Clin.Psychiatry 2004;65(10):1433-1434. View abstract.
Nolte, K. B. and Zumwalt, R. E. Fatal peyote ingestion associated with Mallory-Weiss lacerations. West J.Med. 1999;170(6):328. View abstract.
Pelner, L. Peyote cult, mescaline hallucinations, and model psychosis. N.Y.State J.Med. 11-1-1967;67(21):2838-2843. View abstract.
US Department of Justice. Drug Enforcement Administration. Diversion Control Division. https://www.deadiversion.usdoj.gov/21cfr/cfr/1307/1307_31.htm. Accessed July 5, 2019.
US Drug Enforcement Administration (DEA). Peyote and Mescaline Drug Fact Sheet. Available at: https://www.dea.gov/sites/default/files/2020-06/Peyote%20and%20Mescaline-2020_0.pdf. Accessed on: Nov 2, 2022.